Evidence map›Paper›PMID 40087647›Full record

Observational studyBMC neurology2025

Cognition, mental health, and quality of life in patients with chronic and episodic migraine during the interictal period.

Diana Carolina López-Medina, Alejandra Arboleda-Ramírez, Sara Ríos-Díaz, Renato Zambrano-Cruz, Andrés Arboleda-Jaramillo, Cristian Betancur-Henao, Marcela Henao-Pérez

Abstract readObservational Study
In one paragraph

Observational study in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diana Carolina López-MedinaUniversidad Cooperativa de Colombia, Medellín, Colombia.ORCID http://orcid.org/0000-0003-2098-7319
Alejandra Arboleda-RamírezFundación Instituto Neurológico de Colombia, Medellín, Colombia.ORCID http://orcid.org/0000-0002-0844-2095
Sara Ríos-DíazFundación Instituto Neurológico de Colombia, Medellín, Colombia.ORCID http://orcid.org/0009-0000-5663-6807
Renato Zambrano-CruzUniversidad Cooperativa de Colombia, Medellín, Colombia.ORCID http://orcid.org/0000-0003-2155-0039
Andrés Arboleda-JaramilloUniversidad Cooperativa de Colombia, Medellín, Colombia.ORCID http://orcid.org/0009-0008-8867-1840
Cristian Betancur-HenaoUniversidad Cooperativa de Colombia, Medellín, Colombia.ORCID http://orcid.org/0000-0002-4887-6509
Marcela Henao-PérezUniversidad Cooperativa de Colombia, Medellín, Colombia. marcela.henaop@campusucc.edu.co.ORCID http://orcid.org/0000-0002-7337-2871

Funding

Bill & Melinda Gates Foundation INV-003391Universidad Cooperativa de ​Colombia, Colombia INV3391
6 · The paper itself

Abstract

introductionMigraine is a highly prevalent and disabling condition, not only due to its painful symptoms but also because of its significant impact on mental health and cognitive functioning, leading to a considerable deterioration in quality of life. This study aimed to evaluate the cognitive profile, mental health, and quality of life in patients with chronic and episodic migraine during the interictal period, and to explore their relationship with sociodemographic and clinical variables.

methodThis observational, descriptive, cross-sectional analytical study included 60 patients diagnosed with chronic or episodic migraine, who were enrolled in a health program for headache patients between 2010 and 2016. Cognitive function, anxiety and/or depression symptoms, and quality of life during the interictal period were assessed. Descriptive analyses were conducted, and associations were evaluated by configuring primary (type of migraine) and alternative events (cognitive impairment, depression and/or anxiety, and poor quality of life).

resultsThe mean age of the participants was 45 years (SD ± 8), with 83.3% being women and 93.3% belonging to middle and low socioeconomic strata. Of the 60 patients, 83.3% (50) were diagnosed with chronic migraine, while the remaining had episodic migraine. The use of one or more cognition-altering medications was observed in 90% of patients with chronic migraine and 60% of those with episodic migraine (p = 0.02). Anxiety was more prevalent in patients with episodic migraine, whereas depression was more common among those with chronic migraine. Female gender, middle socioeconomic status, and longer disease duration were significantly associated with chronic migraine. Among the 57 patients who completed the Mini-Mental State Examination, 38.6% had cognitive impairment, which decreased with longer migraine duration and better social interaction. Memory and selective attention were the most affected cognitive domains in both groups. No significant associations were found for the other variables after adjusting for confounders.

conclusionsChronic migraine significantly impacts mental health, cognition, and quality of life, with depression and cognitive impairments being prevalent. Social interaction and longer disease duration may protect against cognitive decline, highlighting the need for multidisciplinary, personalized interventions addressing neurological and psychosocial challenges.

Indexed as

CognitionCognitive DysfunctionMental HealthMigraine DisordersQuality of LifeAdultAnxietyChronic DiseaseCross-Sectional StudiesDepressionFemaleHumansMaleMiddle AgedAnxietyChronic migraineCognitive dysfunctionDepressionEpisodic migraineInterictalMemoryMental healthQuality of lifeSelective attentionSocial support

Identifiers

PMID40087647
PMCPMC11907823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.